NGENF Message Board Post 10044074 | NervGen Pharma Corp -...
home / stock / ngenf / ngenf message board
Jdo
(investorshub)
Posted on: Apr/10/2023 19:33:26
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171652438
This is the year for NGEN-F.
News, Short Squeeze, Breakout and More Instantly...
NervGen Pharma Corp Company Name:
NGENF Stock Symbol:
Market:
-
Bill Radvak to transition to Board Advisor following decision to not stand for re-election to NervGen's Board of Directors Annual General Meeting of Shareholders to be held on June 4, 2024 Vancouver, British Columbia--(Newsfile Corp. - May 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQ...
-
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that it has engaged...
-
Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024 CA$23 million bought deal financing completed in March 2024 provides expected cash runway through Q3 2025 Fast Track designation granted by U.S. Food and Drug Administration (FDA) for NV...